| Primary |
| Rheumatoid Arthritis |
70.7% |
| Product Used For Unknown Indication |
6.4% |
| Hypertension |
4.9% |
| Osteoporosis |
2.9% |
| Prophylaxis |
2.8% |
| Juvenile Idiopathic Arthritis |
2.4% |
| Pain |
1.7% |
| Juvenile Arthritis |
1.2% |
| Diabetes Mellitus |
1.0% |
| Polyarthritis |
0.9% |
| Drug Use For Unknown Indication |
0.8% |
| Hypercholesterolaemia |
0.7% |
| Hypothyroidism |
0.7% |
| Psoriatic Arthropathy |
0.6% |
| Premedication |
0.4% |
| Depression |
0.4% |
| Gastritis |
0.4% |
| Still's Disease Adult Onset |
0.4% |
| Atrial Fibrillation |
0.3% |
| Insomnia |
0.3% |
|
| Pyrexia |
7.2% |
| Sepsis |
7.2% |
| Septic Shock |
7.2% |
| Vomiting |
7.2% |
| Rheumatoid Arthritis |
6.8% |
| Myocardial Infarction |
6.3% |
| Cerebrovascular Accident |
5.9% |
| Urinary Tract Infection |
5.0% |
| Vasculitis |
5.0% |
| Thrombocytopenia |
4.5% |
| Visual Impairment |
4.5% |
| Neutropenia |
4.1% |
| Pneumonia |
4.1% |
| Pulmonary Embolism |
4.1% |
| Transient Ischaemic Attack |
4.1% |
| Death |
3.6% |
| Pain In Extremity |
3.6% |
| Peritonitis |
3.6% |
| Pleural Effusion |
3.2% |
| Psoriasis |
3.2% |
|
| Secondary |
| Rheumatoid Arthritis |
72.7% |
| Prophylaxis |
6.0% |
| Osteoporosis |
4.5% |
| Product Used For Unknown Indication |
4.1% |
| Hypertension |
1.9% |
| Gastritis |
1.8% |
| Juvenile Arthritis |
1.5% |
| Juvenile Idiopathic Arthritis |
1.1% |
| Insomnia |
1.1% |
| Pain |
0.8% |
| Psoriatic Arthropathy |
0.7% |
| Diabetes Mellitus |
0.6% |
| Inflammation |
0.5% |
| Gastrooesophageal Reflux Disease |
0.5% |
| Antibiotic Prophylaxis |
0.4% |
| Systemic Lupus Erythematosus |
0.4% |
| Hypercholesterolaemia |
0.4% |
| Angina Pectoris |
0.3% |
| Neuropathy Peripheral |
0.3% |
| Depression |
0.3% |
|
| Rheumatoid Arthritis |
10.3% |
| Septic Shock |
8.8% |
| Prostate Cancer |
8.3% |
| Demyelinating Polyneuropathy |
5.9% |
| Pancytopenia |
5.9% |
| Sepsis |
5.3% |
| Myocardial Infarction |
5.0% |
| Osteoporosis |
4.7% |
| Pyrexia |
4.4% |
| Vomiting |
4.4% |
| White Blood Cell Count Decreased |
4.4% |
| Spinal Cord Injury |
4.1% |
| Thrombocytopenia |
4.1% |
| Pleurisy |
3.8% |
| Rhinitis |
3.8% |
| Tracheitis |
3.5% |
| Urinary Tract Infection Bacterial |
3.5% |
| Hepatic Enzyme Increased |
3.2% |
| Weight Increased |
3.2% |
| Neutropenia |
2.9% |
|
| Concomitant |
| Rheumatoid Arthritis |
44.0% |
| Product Used For Unknown Indication |
16.0% |
| Mycobacterial Infection |
12.0% |
| Kidney Infection |
8.0% |
| Rheumatic Disorder |
8.0% |
| Ankylosing Spondylitis |
4.0% |
| Osteoporosis |
4.0% |
| Seronegative Arthritis |
4.0% |
|
| Drug Interaction |
33.3% |
| Hyperhidrosis |
16.7% |
| Pustular Psoriasis |
16.7% |
| Rectal Cancer |
16.7% |
| Systemic Mycosis |
16.7% |
|
| Interacting |
| Rheumatoid Arthritis |
61.8% |
| Atrial Fibrillation |
17.6% |
| Osteoporosis |
17.6% |
| Hypertension |
2.9% |
|
| Drug Ineffective |
54.5% |
| Neutropenia |
45.5% |
|
